Author

Martha Gyansa‐Lutterodt

Observed names: Gyansa-Luterrodt, Martha, Gyansa-Lutterodt Martha, Gyansa-Lutterodt, Martha, M Gyansa-Lutterodt, M. Gyansa-Lutterodt, Martha GYANSA-LUTTERODT, Martha Gyansa Lutterodt, Martha Gyansa-Luterrodt, Martha Gyansa-Lutterodt, Martha Gyansa-lutterodt, Martha Gyansah-Lutterodt

Institution: Ministry of Health

Observed institutions: Ministry of Health, Ghana Health Service

ORCID: 0000-0001-6804-1157

Observed ORCID: 0000-0001-6804-1157

OpenAlex ID: A5073717704

Essential medicines for universal health coverage

2016 · Veronika J Wirtz, Hans V Hogerzeil, et al. · The Lancet · 659

Priority-setting for achieving universal health coverage

2016 · Kalipso Chalkidou, Amanda Glassman, et al. · Bulletin of the World Health Organization · 167

Global governance of antimicrobial resistance

2018 · Connor Rochford, Devi Sridhar, et al. · The Lancet · 148

Situational analysis of antibiotic use and resistance in Ghana: policy and regulation

2017 · Saviour Kwame Yevutsey, Kwame Ohene Buabeng, et al. · BMC Public Health · 126

Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana

2015 · Japheth Opintan, Mercy J. Newman, et al. · Infection and Drug Resistance · 111

Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance

2024 · Marc Mendelson, Ramanan Laxminarayan, et al. · The Lancet Global Health · 90

Knowledge of antibiotic resistance and antibiotic prescription practices among prescribers in the Brong Ahafo Region of Ghana; a cross-sectional study

2017 · On behalf of the Ghana Antimicrobial Resistance Working Group, Kwaku Poku Asante, et al. · BMC Health Services Research · 76

Health technology assessment in universal health coverage

2013 · Kalipso Chalkidou, Robert Marten, et al. · The Lancet · 48

Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana

2019 · Mohamed Gad, Johanne Lord, et al. · Value in Health · 37

Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

2019 · Samantha Hollingworth, Martha Gyansa-Lutterodt, et al. · International Journal of Technology Assessment in Health Care · 34

TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana

2005 · JC Cohen, M Gyansa-Lutterodt, et al. · Globalization and Health · 30

The impact of antimicrobial resistance awareness interventions involving schoolchildren, development of an animation and parents engagements: a pilot study

2022 · Bernard Appiah, Lucy Asamoah-Akuoko, et al. · Antimicrobial Resistance and Infection Control · 29

Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes

2021 · Augustina Koduah, Martha Gyansa-Lutterodt, et al. · One Health Outlook · 24

The prevalence and risks of antibiotic self-medication in residents of a rural community in Accra, Ghana

2021 · James-Paul Kretchy, Stephen Kwame Adase, et al. · Scientific African · 24

Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool

2022 · Justice Nonvignon, Richmond Owusu, et al. · Vaccine · 23

What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana

2020 · Samantha A. Hollingworth, Laura Downey, et al. · Health Research Policy and Systems · 23

Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana

2019 · Augustina Koduah, Brian A Asare, et al. · Health Policy and Planning · 22

Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital

2015 · Daniel Kwame Afriyie, Martha Gyansa-Lutterodt, et al. · Pan African Medical Journal · 22

Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study.

2020 · Mary Eyram Ashinyo, Vida Duti, et al. · PubMed · 20

Antibiotic resistance in Ghana

2013 · Martha Gyansa-Lutterodt · The Lancet Infectious Diseases · 19

Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study

2020 · Mary Eyram Ashinyo, Vida Duti, et al. · Pan African Medical Journal · 18

The Pharmaceutical Sector in Ghana

2009 · Martha Gyansa-Lutterodt, Andreas Seiter · World Bank, Washington, DC eBooks · 16

Children against antibiotics misuse and antimicrobial resistance: assessing effectiveness of storytelling and picture drawing as public engagement approaches

2021 · Bernard Appiah, David Anum-Hagin, et al. · Wellcome Open Research · 15

Evidence‐based training and mentorship combined with enhanced outcomes surveillance to address the leading causes of neonatal mortality at the district hospital level in G hana

2014 · Mary N. A. Brantuo, Elizabeth Cristofalo, et al. · Tropical Medicine & International Health · 15

Essential medicines for universal health coverage

2019 · Veronika J Wirtz, Hans V Hogerzeil, et al. · Kazan medical journal · 11

Works count: 50

Citation count: 1,825

H-index: 19

I10-index: 26